FREQUENCIES OF THE MEFV GENE
MUTATIONS IN AZERBAIJAN
Huseynova LS1, Mammadova SN, Aliyeva KAA
*Corresponding Author: Lala S. Huseynova, Ph.D., Department of Medical Biology and Genetics,
Azerbaijan Medical University, Anvar Gasimov Street 14, Baku City AZ1022, Azerbaijan. Tel.: +994-
506-630-623. E-mail: royahuseynova2006@gmail.com
page: 33
|
|
REFERENCES
1. Habahbeh LA, Hiary MA, Zaben SF, Al-Momanu A,
Khawawneh R, Mallouh MA, et al. Genetic profile of
patients with Familial Mediterranean Fever (FMF):
Single cenger experience at King Hussein Medical
Center KHMC). Med Arch. 2015; 69(6): 417-420.
2. Ozen S, Batu ED. The myths we believed in familial
Mediterranean fever: What have we learned in the past
years. Semin Immunopathol. 2015; 37(4): 363-639.
3. Rigante D, Frediani B, Cantarini L. A comprehensive
overview of the hereditary periodic fever syndromes.
Clin Rev Allergy Immunol. 2018; 54(3): 446-453.
4. Anwar GM, Fouad HM, Abd El-Hamid A, Mahmoud
F, Musa N, Lotfi H, et al. A study of familial Mediterranean
Fever (MEFV) gene mutations in Egyptian
children with type 1 diabetes mellitus. Eur J Med
Genet. 2015; 58(1): 31-34.
5. Beheshtian M, Izadi N, Kriegshauser G, Kahrizi K,
Mehr EP, Rostami M, et al. Prevalence of common
MEFV mutations and carrier frequencies in a large
cohort of Iranian populations. J Genet. 2016; 95(3):
667-674.
6. Debeljak M, Toplak N, Abazi N, Szabados B,
Mulaosmanović V, Radović J, et al. The carrier rate
and spectrum of MEFV gene mutations in central
and southeastern European populations. Clin Exp
Rheumatol. 2015; 33(6 Suppl 94): S19-S23.
7. Wu B, Xu T, Li Y, Yin X. Interventions for reducing inflammation
in familial Mediterranean fever. Cochrane
Database Syst Rev. 2018; 10(10): CD010893.
8. Yates AD, Achuthan P, Akanni W, Allen J, Allen J,
Alvaarez-Jarreta J, et al. Ensembl 2020. Nucleic Acids
Res. 2020; 48(D1): D682-D688.
9. Milenković J, Vojinović J, Debeljak M, Toplak N,
Lazarević D, Avčin T, et al. Distribution of MEFV
gene mutations and R202Q polymorphism in the Serbian
population and their influence on oxidative stress
and clinical manifestations of inflammation. Pediatr
Rheumatol Online J. 2016; 14(1):39.
10. Yaşar Bilge Ş, Sarı İ, Solmaz D, Şenel S, Emmungil H,
Kılıç L, et al. The distribution of MEFV mutations in
Turkish FMF patients: Multicenter study representing
results of Anatolia. J Med Sci. 2019; 49(2): 472-477.
11. Yilmaz G, Senes M, Kayalp D, Yucel D. Is Turkish
MEFV mutations spectrum different among regions?.
J Clin Lab Anal. 2016; 30(5):641-644.
12. Zerkaoui M, Laarabi FZ, Ajhoun Y, Chkirate B, Sefiani
A. A novel single variant in the MEFV gene
causing Mediterranean fever and Behçet’s disease:
A case report. J Med Case Rep. 2018; 12(1): 53.
13. Huseynova LS, Aiyeva KA, Najafzada GB, Yusufova
KhJ, Hashimova AR. Molecular-genetic research of
MEFV gene in population of Azerbaijan Republic.
Poland Sylwan. 2018; 162(5):31-36.
14. Rigante D. A developing portrait of hereditary periodic
fevers in childhood. Expert Opin Orphan Drugs.
2018; 6(1): 47-55.
15. Fragouli E, Eliopoulos E, Petraki E, Sidiropoulos P,
Aksentijevich I, Galanakis E, et al. Familial Mediterranean
fever in Crete: A genetic and structural
biological approach in a population of ‘intermediate
risk.’ Clin Genet. 2008; 73(2): 152-159.
16. Jalkh N, Genin E, Chouery E, Delague V, Medlej-
Hashim M, Idrac C-A, et al. Familial Mediterranean
fever in Lebanon: founder effects for different MEFV
mutations. Ann Hum Genet. 2008; 72(10): 41-47.
17. Bonyadi M, Esmaeili M, Jalali H, Somi MH, Ghaffari
A, Rafeey M, et al. MEFV mutations in Iranian Azeri
Turkish patients with familial Mediterranean fever.
Clin Genet. 2009; 76(11): 477-480.
18. Otsuka M, Koga T, Sumiyoshi R, Koike Y, Furukawa
K, Okamoto M, et al. A case of neutrophilic dermatosis
with MEFV gene variant and abnormal activation
of peripheral blood monocytes: A case report. Immun
Med. 2019; 42(6): 45-49.
19. Berg JS, Adams M, Nassar N, Bizon C, Lee K, Schmitt
CP, et al. An informatics approach to analyzing the
incidentalome. Genet Med. 2013; 15(1): 36-44.
20. Masters SL, Lagou V, Jeru I, Baker PJ, Van Eyck L,
Parry DA, et al. Familial autoinflammation with neutrophilic
dermatosis reveals a regulatory mechanism
of pyrin activation. Sci Transl Med. 2016; 8: 332-345. 21. Kiyota M, Oya M, Ayano M, Niiro H, Iwasaki T,
Fujiwara M, et al. First case of pyrin-associated autoinflammation
with neutrophilic dermatosis complicated
by amyloidosis. Rheumatology (Oxford). 2020;
59(9): e.41-e43.
22. Moghaddas F, Llamas R, De Nardo D, Martinez-Banaclocha
H, Martinez-Garcia JJ, Mesa-del-Castillo
P, et al. A novel pyrin-associated autoinflammation
with neu-trophilic dermatosis mutation further defines
14-3-3 binding of pyrin and distinction to familial
Mediterranean fever. Ann Rheum Dis. 2017; 76(12):
2085-2094.
23. Grossman C, Kassel Y, Livneh A, Ben-Zvi I. Familial
Mediterranean fever (FMF) phenotype in patients
homozygous to the MEFV M694V mutation. Eur J
Med Genet. 2019; 62(6): 103532.
24. Mattit H, Joma M, Al-Cheikh S, El-Khateeb M,
Medlej-Hashin M, Salem N, et al. Familial Mediterranean
fever in the Syrian population: Gene mutation
frequencies, carrier rates and phenotype-genotype
correlation. Eur J Med Genet. 2006; 49(6): 481-486.
25. Jarjour RA. Familial Mediterranean fever in Syrian
patients: MEFV gene mutations and genotype-phenotype
correlation. Mol Biol Rep. 2010; 37(1): 1-5.
26. Jarjour RA, Dodaki R. Arthritis patterns in familial
Mediterranean fever patients and association with
M694V mutation. Mol Biol Rep. 2011; 38(3): 2033-
2036.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
